Bank of America Hit With $1.2 Billion Fine Over Money Laundering Failures 
SpaceX Starlink Restrictions Disrupt Ukraine Military Operations 
Canton Network Expands Wall Street Reach With Ripple Integration 
Ripple Mints 19.6 Million RLUSD Amid Banking Expansion 
MNX Crypto Exchange Launches Futures for OpenAI, Anthropic Valuations 
Alibaba Unveils Qwen AI Smart Glasses, Shares Rise 2% 
AT&T Sells Mexico Wireless Business to Televisa for $2 Billion 
Nvidia’s China AI Chip Market Share Falls to 34% as Huawei Gains Ground 
Tesla Holds $960 Million in Bitcoin as BTC Gains Top $710 Million 
OpenAI Uses AI to Uncover Hidden Recording Device, FBI Makes Arrest 
Bumble Shares Surge 50% on $1 Billion Buyout Talks 
Citi Upgrades Galaxy Digital Stock, Raises Price Target to $28 
Interactive Brokers Launches Ethereum Staking With Zerohash 
Most Americans Oppose Election Betting on Prediction Markets, Poll Finds 
Arm Breaches Qualcomm License Deal, Jury Awards $2 
Add as a preferred source on Google
VALENCIA, Calif., March 07, 2016 -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) will release its 2015 fourth quarter and full year financial results on Monday, March 14, 2016 and its management will host a conference call to discuss the fourth quarter and full year financial results and other Company developments at 5:00 PM (Eastern Time) on March 14, 2016.
Presenting from the Company will be its Chief Executive Officer, Matthew Pfeffer and other members of senior management.
To participate in the live call by telephone, please dial (888) 771-4371 or (847) 585-4405 and use the participant passcode: 42014510. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at http://www.mannkindcorp.com.
A telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing (888) 843-7419 or (630) 652-3042 and use the participant passcode: 4201 4510#. A replay will also be available on MannKind's website for 14 days.
About MannKind Corporation
MannKind Corporation (NASDAQ and TASE: MNKD) focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.
Company Contact: Matthew J. Pfeffer Chief Executive Officer 661-775-5300 [email protected]
